Clinical Data Disclosure: PhRMA Principles Rely On Review Boards To Screen Research Proposals
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA and EFPIA issue joint principles that urge firms to release the synopses of clinical study reports; PhRMA objects to FDA’s proposal to release masked, de-identified data on the grounds of patient privacy, competitive secrecy.